Dynamic contrast enhanced MRI of the axilla in women with breast cancer: Comparison with pathology of excised nodes

British Journal of Radiology

Volumn 75, Issue 891, 2002, Pages 220-228

  Murray, A D ^a   Staff, R T ^a   Redpath, T W ^a   Gilbert, F J ^a   Ah See, A K ^a   Brookes, J A ^a   Miller, I D ^a   Payne, S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST CANCER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; QUANTITATIVE ANALYSIS; RELIABILITY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0036228222     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.891.750220     Document Type: Article

References (51)

1. Pathologic correlates of prognosis in lymph node-positive breast carcinomas
2. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer
3. Omission of axillary lymph node dissection in early-stage breast cancer: Effect on treatment outcome
4. Impact of axillary lymph node dissection on the therapy of breast cancer patients
5. The need to reexamine axillary lymph node dissection in invasive breast cancer
6. MR imaging of the breast using gadolinium-DTPA
7. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathological correlation
8. Non-palpable breast tumours: Diagnosis with contrast-enhanced subtraction dynamic MR imaging
9. Half-Fourrier, three-dimensional technique for dynamic contrast-enhanced MR imaging of both breasts and axillae: Initial characterisation of breast lesions
10. Characterisation of lymphadenopathy by magnetic resonance relaxation times: Preliminary results
11. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging
12. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma
13. Significance of axillary macrometastases and micrometastases in mammary cancer
14. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data
15. A new approach for testing the significance of differences between ROC curves measured from correlated data
16. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants
17. MR characterisation of suspicious breast lesions with a gadolinium-enhanced turboFLASH subtraction technique
18. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI
19. MR imaging of the breast
20. A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions
21. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: Preliminary experience
22. Choice of contrast enhancement index for dynamic magnetic resonance mammography
23. Axillary lymph node MRI with Sinerem® in patients with suspected breast cancer
24. Inefficacy of internal mammary nodes dissection in breast cancer surgery
25. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
26. Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: Detection by immunohistochemistry and prognostic significance
27. Occult regional lymph node metastases from breast carcinoma: Immunohistological detection with antibodies CAM 5.2 and NCRC-11
28. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
29. Pathological findings from the national surgical adjuvant breast project
30. Micrometastases to axillary lymph nodes from carcinoma of the breast: Detection by immunohistochemistry and prognostic significance
31. Detection and significance of occult metastases in node-negative breast cancer
32. Axillary micro- and macro metastases in breast cancer
33. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
34. Axillary node micrometastases: Detection and biologic significance
35. Axillary lymph node metastases in breast cancer: Preoperative detection with dynamic contrast enhanced MRI
36. The axillary lymph nodes in breast cancer. Seven years on
37. Xeroradiography of axillary lymph disease
38. Axillary lymph node metastases in breast cancer: Preoperative detection with US
39. Colour Doppler studies of axillary lymph node metastases in breast carcinoma
40. CT-pathologic correlation of axillary lymph nodes in breast carcinoma
41. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement
42. Detection of axillary lymph node metastases in breast carcinoma by technetium-99m-sestamibi breast scintigraphy, ultrasound and conventional mammography
43. Evaluation of breast masses and axillary lymph nodes with (F-18) 2-deoxy-2-fluoro-D-glucose PET
44. Positron emission tomography with fluoro-18-deoxyglucose in the detection and staging of breast cancer
45. Axillary lymph node metastases; Screening with (F-18) 2-deoxy-2-fluoro-D-glucose (FDG) PET
46. 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: Implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases
47. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
48. Scintigraphic identification of sentinel lymph node in breast carcinoma
49. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
50. Gamma-probe guided resection of the sentinel node in breast cancer